Clinical Nurse Specialist Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Marc Kovalchik

Clinical Nurse Specialist, Psychiatric/Mental Health, Adult Wilkes Barre, PA Clinical Nurse Specialist

NPI 1871925842 CMS profile 11002214

1111 E End Blvd, Wilkes Barre, PA 18711

Open in the dashboard

General payments

$4,425

285 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Marc Kovalchik of Wilkes Barre, PA is reported in the CMS Open Payments database as having received $4,425 across 285 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Clinical Nurse Specialist, Psychiatric/Mental Health, Adult profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,143 76
2024 General $1,139 73
2023 General $1,131 71
2022 General $524 34
2021 General $489 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Marc Kovalchik
  • Clinical Nurse Specialist, Psychiatric/Mental Health, Adult median
  • Middle half of Clinical Nurse Specialist, Psychiatric/Mental Health, Adult
  • National median

In program year 2025, general payments to Marc Kovalchik were reported at $1,143. Among 197 Clinical Nurse Specialist, Psychiatric/Mental Health, Adult profiles paid that year, the median was $174 and the middle half received between $71 and $653.

Show as a table
Year Marc Kovalchik Clinical Nurse Specialist, Psychiatric/Mental Health, Adult median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $489 $152 $38–$472 $132
2022 $524 $172 $73–$546 $149
2023 $1,131 $156 $56–$560 $160
2024 $1,139 $158 $39–$521 $164
2025 $1,143 $174 $71–$653 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $662 49 payments
  2. ITI, Inc. $583 35 payments
  3. Otsuka America Pharmaceutical, Inc. $562 34 payments
  4. Lundbeck LLC $545 41 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $512 36 payments
  6. Neurocrine Biosciences, Inc. $485 29 payments
  7. Bausch Health US, LLC $364 18 payments
  8. Vanda Pharmaceuticals Inc. $174 11 payments
  9. Alkermes, Inc. $170 11 payments
  10. Ironshore Pharmaceuticals Inc. $72 5 payments
  11. Other $296 16 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,379 284 payments
  2. Education $47 1 payment
Products named General payments · program years 2021–2025
  1. VRAYLAR $662 49 payments
  2. REXULTI Psychiatry $545 41 payments
  3. TRINTELLIX $512 36 payments
  4. REXULTI Psychiatry $507 31 payments
  5. INGREZZA $438 26 payments
  6. CAPLYTA Psychiatry $379 22 payments
  7. APLENZIN $364 18 payments
  8. WELLBUTRIN $242 12 payments
  9. CAPLYTA Psychiatry $204 13 payments
  10. ABILIFY MAINTENA $191 11 payments
  11. Other $1,679 105 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

285 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Nurse Specialist, Psychiatric/Mental Health, Adult in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record